Coexistence of EGFR , KRAS , BRAF , and PIK3CA Mutations and ALK Rearrangement in a Comprehensive Cohort of 326 Consecutive Spanish Nonsquamous NSCLC Patients-Reference-Cited by-同舟云学术

Coexistence of EGFR , KRAS , BRAF , and PIK3CA Mutations and ALK Rearrangement in a Comprehensive Cohort of 326 Consecutive Spanish Nonsquamous NSCLC Patients

Published:2017-11 Issue:6 Volume:18 Page:e395-e402
ISSN:1525-7304
Container-title:Clinical Lung Cancer
language:en
Short-container-title:Clinical Lung Cancer

Author:

Martín Martorell Paloma^ORCID,Huerta Marisol,Compañ Quilis Amparo,Abellán Rosario,Seda Enrique,Blesa Sebastián,Chaves Felipe J.,Dualde Beltrán Diego^ORCID,Roselló Keränen Susana,Franco José,Insa Amelia

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference32 articles.

1. Cancer statistics 2016;Spiegel;Cancer J Clin,2016

2. Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small cell lung cancer to gefitinib;Lynch;N Engl J Med,2004

3. EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy;Paez;Science,2004

4. EGF receptor gene mutations are common in lung cancers from “never smokers” and are associated with sensitivity of tumors to gefitinib and erlotinib;Pao;Proc Natl Acad Sci U S A,2004

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Estudio de variantes genéticas en 169 pacientes de cáncer de pulmón no microcítico;Revista Española de Patología;2023-10

2. KRAS G12C mutated advanced non-small cell lung cancer (NSCLC): Characteristics, treatment patterns and overall survival from a Danish nationwide observational register study;Lung Cancer;2023-04

3. Challenges of neoadjuvant targeted therapy in early stage non-small cell lung cancer—a narrative review;AME Surgical Journal;2023-04

4. BRAF Inhibitors in Non-Small Cell Lung Cancer;Cancers;2022-10-05

5. Molecular Biology and Therapeutic Perspectives for K-Ras Mutant Non-Small Cell Lung Cancers;Cancers;2022-08-24